These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 25809179)
1. Inhaled technosphere insulin: a novel delivery system and formulation for the treatment of types 1 and 2 diabetes mellitus. Kugler AJ; Fabbio KL; Pham DQ; Nadeau DA Pharmacotherapy; 2015 Mar; 35(3):298-314. PubMed ID: 25809179 [TBL] [Abstract][Full Text] [Related]
2. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus. Pham DQ; Cohen H; Chu V J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117 [TBL] [Abstract][Full Text] [Related]
3. A review of inhaled technosphere insulin. Neumiller JJ; Campbell RK; Wood LD Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362 [TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis. Pittas AG; Westcott GP; Balk EM Lancet Diabetes Endocrinol; 2015 Nov; 3(11):886-94. PubMed ID: 26341170 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus. Ceglia L; Lau J; Pittas AG Ann Intern Med; 2006 Nov; 145(9):665-75. PubMed ID: 17088580 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial. Raskin P; Heller S; Honka M; Chang PC; Boss AH; Richardson PC; Amin N Diabetes Obes Metab; 2012 Feb; 14(2):163-73. PubMed ID: 21951325 [TBL] [Abstract][Full Text] [Related]
12. Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route. Pfützner A; Mann AE; Steiner SS Diabetes Technol Ther; 2002; 4(5):589-94. PubMed ID: 12450439 [TBL] [Abstract][Full Text] [Related]
13. First inhaled insulin product approved. FDA Consum; 2006; 40(2):28-9. PubMed ID: 16671198 [TBL] [Abstract][Full Text] [Related]
16. Pulmonary insulin delivery by means of the Technosphere drug carrier mechanism. Pfützner A; Forst T Expert Opin Drug Deliv; 2005 Nov; 2(6):1097-106. PubMed ID: 16296812 [TBL] [Abstract][Full Text] [Related]
17. Review of phase 2 studies utilizing the AIR particle technology in the delivery of human insulin inhalation powder versus subcutaneous regular or lispro insulin in subjects with type 1 or type 2 diabetes. Ellis SL; Gemperline KA; Garg SK Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S48-56. PubMed ID: 17563304 [TBL] [Abstract][Full Text] [Related]
18. Inhaled insulin for diabetes mellitus. Mandal TK Am J Health Syst Pharm; 2005 Jul; 62(13):1359-64. PubMed ID: 15972377 [TBL] [Abstract][Full Text] [Related]
19. Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial. Fineberg SE; Kawabata T; Finco-Kent D; Liu C; Krasner A J Clin Endocrinol Metab; 2005 Jun; 90(6):3287-94. PubMed ID: 15741258 [TBL] [Abstract][Full Text] [Related]
20. [A new therapeutic option for diabetes patients]. Mihălţan F; Ulmeanu R; Râşnoveanu R Pneumologia; 2005; 54(4):181-5. PubMed ID: 17069221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]